These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22002751)

  • 1. MR in hypertension.
    Roditi G
    J Magn Reson Imaging; 2011 Nov; 34(5):989-1006. PubMed ID: 22002751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging of the kidneys and adrenal glands.
    Davarpanah AH; Israel GM
    Radiol Clin North Am; 2014 Jul; 52(4):779-98. PubMed ID: 24889171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of the adrenal gland and kidney.
    Brown ED; Semelka RC
    Top Magn Reson Imaging; 1995; 7(2):90-101. PubMed ID: 7772374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding and interpreting MRI of the genitourinary tract.
    Bassignani MJ
    Urol Clin North Am; 2006 Aug; 33(3):301-17. PubMed ID: 16829266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular manifestations of autosomal dominant polycystic kidney disease in young adults.
    Handa SP
    Clin Invest Med; 2006 Dec; 29(6):339-46. PubMed ID: 17330449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging of the liver, kidneys, and adrenal glands.
    Glazer GM
    Radiology; 1988 Feb; 166(2):303-12. PubMed ID: 3275974
    [No Abstract]   [Full Text] [Related]  

  • 8. MR imaging of the kidneys and adrenal glands.
    Israel GM; Krinsky GA
    Radiol Clin North Am; 2003 Jan; 41(1):145-59. PubMed ID: 12630690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtraction imaging: applications for nonvascular abdominal MRI.
    Newatia A; Khatri G; Friedman B; Hines J
    AJR Am J Roentgenol; 2007 Apr; 188(4):1018-25. PubMed ID: 17377038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated evaluation of hypertensive patients with cardiovascular magnetic resonance.
    Maceira AM; Prasad SK; Pennell DJ; Mohiaddin RH
    Int J Cardiol; 2008 Apr; 125(3):383-90. PubMed ID: 17475351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
    Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
    Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging hypertrophic heart diseases with cardiovascular MR.
    Proctor RD; Shambrook JS; McParland P; Peebles CR; Brown IW; Harden SP
    Clin Radiol; 2011 Feb; 66(2):176-86. PubMed ID: 21216334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging of the kidneys and adrenal glands.
    Baumgartner BR; Chezmar JL
    Semin Ultrasound CT MR; 1989 Feb; 10(1):43-62. PubMed ID: 2697325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current indications for magnetic resonance in non-neurological pathology (II)].
    Gómez González J; Muñoz González A; Rosen B
    Med Clin (Barc); 1989 May; 92(17):665-75. PubMed ID: 2664381
    [No Abstract]   [Full Text] [Related]  

  • 15. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
    J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Values for blood creatinine in aged persons. Anatomo-clinical study of 253 cases].
    Beck H; Eldib SK; Larouze B
    Gerontol Clin (Basel); 1972; 14(2):89-99. PubMed ID: 4665888
    [No Abstract]   [Full Text] [Related]  

  • 17. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
    Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R;
    Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat chromosome 19 transfer from SHR ameliorates hypertension, salt-sensitivity, cardiovascular and renal organ damage in salt-sensitive Dahl rats.
    Wendt N; Schulz A; Siegel AK; Weiss J; Wehland M; Sietmann A; Kossmehl P; Grimm D; Stoll M; Kreutz R
    J Hypertens; 2007 Jan; 25(1):95-102. PubMed ID: 17143179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation.
    Dawood T; Schlaich MP
    Minerva Cardioangiol; 2009 Dec; 57(6):687-704. PubMed ID: 19942842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.